Micro-Dose, Macro-Impact: Leveraging Psychedelics in Frontline Healthcare Workers During the COVID-19 Pandemic

A retrospective chart review of an open-label trial of low-dose ketamine administered to front-line healthcare workers who were identified as experiencing acute stress disorder due to the COVID-19 Pandemic.

Topic PTSD Microdosing
Compound Ketamine
Country United States of America
Visit trial
Status Active, not recruiting
Results Published No
Start date 15 April 2020
End date 01 April 2021
Chance of happening 100%
Phase Phase IV
Design Open
Type Interventional
Generation First
Participants 30
Sex All
Age 18- 99
Therapy No

Trial Details

An investigation of a novel, off-label use of an FDA approved drug (ketamine) in a low(micro) dose sublingual formulation of ketamine provided to front-line healthcare workers who were identified as suffering from acute stress disorder. The study was conducted completely virtually via real-time telemedicine for physician visits and via asynchronous interaction for outcomes data collection. Patients self-referred to the study via email outreach, and diagnosis was confirmed by medically validated screening assessments and study physician confirmation. Once treatment was initiated, patients were seen via live telemedicine every 40 days while treatment response/outcomes data was collected weekly and monthly. Patients were treated up to 120 days.

NCT Number NCT04769297

Sponsors & Collaborators

Limbic Medical
Limbic Medical investigate the underlying factors of pain, addiction, and mood disorders to customize an innovative whole-body approach to relieve suffering and achieve a balanced state of being.

Enovex Pharmacy
This company doesn't have a full profile yet, it is linked to a clinical trial.

Data attribution

A large set of the trials in our database are sourced from ClinicalTrials.gov (CTG). We have modified these post to display the information in a more clear format or to correct spelling mistakes. Our database in actively updated and may show a different status (e.g. completed) if we have knowledge of this update (e.g. a published paper on the study) which isn't reflected yet on CTG. If a trial is not sourced from CTG, this is indicated on this page and you can follow the link to the alternative source of information.